The U.S. Food and Drug Administration (FDA) has approved labeling for a generic itraconazole oral capsule submitted by Jubilant Generics under application number ANDA203445.
The product, identified as ITRACONAZOLE 100 MG capsule, is marked with a discontinued marketing status and is not a reference listed drug.
The original submission (submission 1) received approval on 23 Feb 2017, and subsequent labeling supplements (submissions 1, 2, and 5) were approved on 25 Oct 2019.
Actualités réglementaires16 sept. 2026•3 min de lecture
FDA Approves Jubilant Itraconazole 100 mg Capsule (ANDA203445)
FDA approved labeling for Jubilant Generics' oral itraconazole 100 mg capsule (ANDA203445); the product is listed as discontinued.
Compilé par l'équipe Pharmacountry · Source : FDA.gov
Sujets :
Évaluations
(0)
(0)
(0)
(0)
(0)
Laissez votre note